U.S. Cosmetic Ingredient Order

Separate ingredient ranking from concentration, understand the exceptions, and ask for.

Rows of skin-care bottles, tubes and cartons with shelf labels in a drugstore
Retail context only: skin-care shelves in Colatina, Brazil, photographed by ArionStar on February4,2024 (CC0). This image does not establish U.S. label compliance, ingredients, concentrations, safety or efficacy; it is not the author’s store visit or a product recommendation.
On this page
  1. Order rules and their exceptions
  2. A fictional rank-and-amount sketch
  3. A paraben is not a percentage marker
  4. Drug-cosmetic labels and missing documentation
  5. A label is a list, not a recipe
  6. The question to carry into the shop

📌 FDA & Cosmetics Safety Hub: browse all 7 guides »

No. Ingredient position alone generally cannot establish an exact percentage in an ordinary U.S. cosmetic. Rank is not a concentration measurement. A missing name is a different gap again — it does not rule a substance out, as the gel nail polish remover warning shows: see FDA’s Gel Nail Polish Remover Warning: Why a Missing Ingredient Name Does Not Rule Out Methylene Chloride. FDA ingredient-name guidance.

Order rules and their exceptions

FDA describes retail cosmetic ingredient lists as generally descending by predominance. FDA retail-label explanation.

Its labeling summary permits color additives and ingredients present at 1% or less to appear without predominance ordering. Those exceptions matter before interpreting any position. FDA ordering exceptions.

A fictional rank-and-amount sketch

Assume fictional ingredients A, B and C occupy a descending-order segment. This is a reasoning example, not a product label or measured formula.

Fictional ingredientAssumed rankExact amount
AFirstNot provided
BSecondNot provided
CThirdNot provided

A can be at least as abundant as B, and B as C, without fixing their amounts. Different gaps can preserve the ranking: the constraint does not select one formula. This is an editorial inference from the ordering principle. FDA ordering context.

A paraben is not a percentage marker

The captured exceptions concern ingredient category or amount, not a paraben’s position. They do not support treating that position as a universal 1% boundary. This is an inference, not an additional FDA rule. FDA exception wording.

Drug-cosmetic labels and missing documentation

For cosmetics that are also drugs, FDA’s summary places identified active drug ingredients before cosmetic ingredients. Do not read that combined sequence as one concentration ranking. FDA drug-cosmetic distinction.

A focused manufacturer question is: Can you document this ingredient’s concentration in this exact product version? Record an unanswered amount as unknown. The same question-first approach works for PFAS: record exactly what the label says, then ask the manufacturer — see PFAS in U.S. Cosmetics: What Labels Reveal—and What to Ask Next. Keep any supplied percentage with its document, product identity and date; do not substitute a position-based estimate.

A label is a list, not a recipe

It helps to say plainly what an ingredient list is. It is a list of what is in the product, in a generally descending order, with the exceptions this article describes — color additives and ingredients at 1% or less need not follow predominance order. What it is not is a recipe. A recipe tells you how much of each thing went in; a label does not. The first ingredient may be present at 40% or at 4%, and nothing on the label will tell you which. That is not a flaw in the label; it is the limit of what a list can do. Once you accept that limit, the list becomes useful again — for spotting what is present, what is absent, and what to ask about next, rather than for guessing amounts it was never designed to reveal.

The question to carry into the shop

The article ends with one question, and it is worth carrying with you: can you document this ingredient’s concentration in this exact product version? That question does three quiet jobs at once. It keeps you from treating a rank as an amount. It separates the product in your hand from other versions with the same name. And it turns an unanswered amount into a recorded unknown instead of a silent guess. If the manufacturer can answer, keep the answer with its document, the product identity and the date. If it cannot, that is also an answer — not a reason to estimate from the label, but a reason to decide with the gap in full view.

Source check date: October 26, 2026, using supplied FDA captures, not a live check. Refresh this explanation if the cited rules change. No product concentrations, efficacy or allergy suitability were assessed.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *